Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Pemigatinib is a kinase inhibitor indicated for the treatment of adult patients ···【more】
Release date：2026-03-27Recommended：60
Side Effects of AxitinibUnderstanding the possible side effects that may occur d···【more】
Release date：2026-03-26Recommended：49
Side Effects of TazemetostatAs a drug used for treating certain tumors, tazemeto···【more】
Release date：2026-03-26Recommended：59
Larotrectinib may cause a range of side effects and adverse reactions, varying f···【more】
Release date：2026-03-26Recommended：58
The specific treatment regimen for tazemetostat should be determined by a qualif···【more】
Release date：2026-03-26Recommended：50
Pirtobrutinib is a BTK inhibitor developed by Eli Lilly and Company in the Unite···【more】
Release date：2026-03-25Recommended：51
During treatment with pirtobrutinib, some side effects may occur, and these effe···【more】
Release date：2026-03-25Recommended：53
For Patients with Severe Renal Impairment(1). If the current dose is 200 mg once···【more】
Release date：2026-03-25Recommended：55
Pirtobrutinib is a non-covalent (reversible) Bruton's tyrosine kinase (BTK) ···【more】
Release date：2026-03-25Recommended：59
Enasidenib helps restore the normal differentiation of leukemia cells by inhibit···【more】
Release date：2026-03-24Recommended：33
The dosage and administration of enasidenib must strictly follow medical advice ···【more】
Release date：2026-03-24Recommended：42
The use of tepotinib must strictly adhere to the principle of individualized tre···【more】
Release date：2026-03-24Recommended：38
